150 related articles for article (PubMed ID: 22647765)
1. Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw.
Bocanegra-Pérez S; Vicente-Barrero M; Knezevic M; Castellano-Navarro JM; Rodríguez-Bocanegra E; Rodríguez-Millares J; Pérez-Plasencia D; Ramos-Macías A
Int J Oral Maxillofac Surg; 2012 Nov; 41(11):1410-5. PubMed ID: 22647765
[TBL] [Abstract][Full Text] [Related]
2. Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients.
Coviello V; Peluso F; Dehkhargani SZ; Verdugo F; Raffaelli L; Manicone PF; D' Addona A
J Biol Regul Homeost Agents; 2012; 26(1):151-5. PubMed ID: 22475108
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-related osteonecrosis of the jaws--an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma.
Curi MM; Cossolin GS; Koga DH; Zardetto C; Christianini S; Feher O; Cardoso CL; dos Santos MO
J Oral Maxillofac Surg; 2011 Sep; 69(9):2465-72. PubMed ID: 21763050
[TBL] [Abstract][Full Text] [Related]
4. Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases.
Mozzati M; Gallesio G; Arata V; Pol R; Scoletta M
Oral Oncol; 2012 May; 48(5):469-74. PubMed ID: 22265335
[TBL] [Abstract][Full Text] [Related]
5. Cell therapy in bisphosphonate-related osteonecrosis of the jaw.
Gonzálvez-García M; Rodríguez-Lozano FJ; Villanueva V; Segarra-Fenoll D; Rodríguez-González MA; Oñate-Sánchez R; Blanquer M; Moraleda JM
J Craniofac Surg; 2013 May; 24(3):e226-8. PubMed ID: 23714970
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
[TBL] [Abstract][Full Text] [Related]
7. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S
Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160
[TBL] [Abstract][Full Text] [Related]
8. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
[TBL] [Abstract][Full Text] [Related]
9. Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report.
Soydan SS; Uckan S
J Oral Maxillofac Surg; 2014 Feb; 72(2):322-6. PubMed ID: 24075235
[TBL] [Abstract][Full Text] [Related]
10. Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study.
Kim JW; Kim SJ; Kim MR
Br J Oral Maxillofac Surg; 2014 Nov; 52(9):854-9. PubMed ID: 25138613
[TBL] [Abstract][Full Text] [Related]
11. Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws.
Lee CY; Pien FD; Suzuki JB
Implant Dent; 2011 Oct; 20(5):331-6. PubMed ID: 21881516
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model.
Barba-Recreo P; Del Castillo Pardo de Vera JL; Georgiev-Hristov T; Ruiz Bravo-Burguillos E; Abarrategi A; Burgueño M; García-Arranz M
J Craniomaxillofac Surg; 2015 Sep; 43(7):1161-8. PubMed ID: 26027865
[TBL] [Abstract][Full Text] [Related]
13. Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
Inchingolo F; Cantore S; Dipalma G; Georgakopoulos I; Almasri M; Gheno E; Motta A; Marrelli M; Farronato D; Ballini A; Marzullo A
J Biol Regul Homeost Agents; 2017; 31(3):811-816. PubMed ID: 28958140
[TBL] [Abstract][Full Text] [Related]
14. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin.
Gönen ZB; Yılmaz Asan C
Cranio; 2017 Sep; 35(5):332-336. PubMed ID: 27363584
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hemimandibular paresthesia in a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) by combining surgical resection and PRGF-Endoret.
Anitua E; Begoña L; Orive G
Br J Oral Maxillofac Surg; 2013 Dec; 51(8):e272-4. PubMed ID: 23201057
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-associated osteonecrosis of the jaws -- report of three cases in Bulgaria and review of the literature.
Pechalova P; Bakardjiev A; Zaprianov Z; Vladimirov B; Poriazova E; Zheleva A; Hadjigeorgiev G; Goranova-Marinova V; Goranov S
Acta Clin Croat; 2011 Jun; 50(2):273-9. PubMed ID: 22263396
[TBL] [Abstract][Full Text] [Related]
18. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.
Freiberger JJ; Padilla-Burgos R; McGraw T; Suliman HB; Kraft KH; Stolp BW; Moon RE; Piantadosi CA
J Oral Maxillofac Surg; 2012 Jul; 70(7):1573-83. PubMed ID: 22698292
[TBL] [Abstract][Full Text] [Related]
19. Use of Leukocyte- and Platelet-Rich Fibrin in the Treatment of Medication-Related Osteonecrosis of the Jaws.
Maluf G; Caldas RJ; Silva Santos PS
J Oral Maxillofac Surg; 2018 Jan; 76(1):88-96. PubMed ID: 28675810
[TBL] [Abstract][Full Text] [Related]
20. Photodynamically dealing with bisphosphonate-related osteonecrosis of the jaw: Successful case reports.
de Castro MS; Ribeiro NV; de Carli ML; Pereira AA; Sperandio FF; Hanemann JA
Photodiagnosis Photodyn Ther; 2016 Dec; 16():72-75. PubMed ID: 27585753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
